|
Issue |
Title |
|
Vol 56, No 5 (2018) |
POTENTIAL HARMS OF THE USE OF PROTON PUMP INHIBITORS: DEBATABLE PROBLEMS |
Abstract
PDF (Rus)
|
Yu. V. Muravyev, O. R. Bobkova |
|
Vol 56, No 4 (2018) |
WHAT ADVERSE REACTIONS TO BIOLOGICAL AGENTS ARE PARADOXICAL? |
Abstract
PDF (Rus)
|
Yu. V. Muravyev |
|
Vol 56, No 3 (2018) |
DEFINITION OF THE TERM «RHEUMATOLOGY»: DO WE NEED THIS AND HOW DO THE EULAR AND THE ACR LOOK AT THIS? |
Abstract
PDF (Rus)
|
Sh. F. Erdes |
|
Vol 56, No 1 (2018) |
DEBATABLE PROBLEMS OF PHARMACOVIGILANCE |
Abstract
PDF (Rus)
|
Yu. V. Muravyev, L. A. Muravyevа |
|
Vol 55, No 6 (2017) |
A NEW CONCEPT OF SPONDYLOARTHRITIS: A COMPROMISE BETWEEN ASAS AND GRAPPA? |
Abstract
PDF (Rus)
|
Sh. F. Erdes |
|
Vol 55, No 5 (2017) |
A RESPONSE TO «PRECISION» CRITICS |
Abstract
PDF (Rus)
|
A. E. Karateev |
|
Vol 55, No 5 (2017) |
DISCUSSION IDEAS ABOUT MEDICINE AMBIGUITIES |
Abstract
PDF (Rus)
|
Yu. V. Muravyev, L. A. Muravyev |
|
Vol 55, No 4 (2017) |
IS THE PATIENT PARTNERSHIP INFORMATIVE IN PHARMACOVIGILANCE? |
Abstract
PDF (Rus)
|
Yu. V. Muravyev |
|
Vol 55, No 4 (2017) |
DRAFT NATIONAL CLINICAL GUIDELINES (GENERAL PROVISIONS) RATIONAL USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS According to the results of the expert group meeting, Moscow, 01.04.2017 |
Abstract
PDF (Rus)
|
A. E. Karateev |
|
Vol 55, No 3 (2017) |
USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN PATIENTS WITH HIGH CARDIOVASCULAR RISK |
Abstract
PDF (Rus)
|
Yu. A. Olyunin |
|
Vol 55, No 3 (2017) |
WHY IS THE STUDY OF THE COMPLEX SAFETY OF CELECOXIB FOR ARTHRITIS, WHICH IS CALLED PRECISION, LAST BUT NOT LEAST? |
Abstract
PDF (Rus)
|
Yu. V. Muravyev |
|
Vol 55, No 2 (2017) |
WHAT TO DO WITH A VARIETY OF TERMS THAT REFLECT THE HARM OF DRUGS? |
Abstract
PDF (Rus)
|
Yu. V. Muravyev, L. A. Muravyeva |
|
Vol 55, No 1 (2017) |
WHY ARE THE RECOMMENDED METHOTREXATE DOSES NOT USED FOR THE TREATMENT OF RHEUMATOID ARTHRITIS: WHO IS GUILTY AND WHAT TO DO? |
Abstract
PDF (Rus)
|
Yu. V. Muravyev, E. L. Nasonov |
|
Vol 54, No 4 (2016) |
The evolution of discussion ideas on drug-induced disease |
Abstract
PDF (Rus)
|
Yu. V. Muravyev, L. A. Muravyeva |
|
Vol 54, No 3 (2016) |
TARDY IDEAS ON THE USE OF BIOLOGICAL AGENTS IN RHEUMATIC DISEASES |
Abstract
PDF (Rus)
|
Yu. V. Muravyev, L. A. Muravyeva |
|
Vol 53, No 3 (2015) |
DRUG SAFETY DATA COVERAGE IN MEDICAL LITERATURE |
Abstract
PDF (Rus)
|
Yu. V. Muravyev, L. A. Muravyeva |
|
Vol 53, No 2 (2015) |
PALLIATIVE CARE IN SPONDYLOARTHRITIS: IS THERE A NEED FOR THIS? |
Abstract
PDF (Rus)
|
A. P. Rebrov, A. I. Akulova, I. Z. Gaidukova |
|
Vol 52, No 6 (2014) |
IS PSORIATIC ARTHRITIS REALLY PSORIATIC? |
Abstract
PDF (Rus)
|
Sh. F. Erdes |
|
Vol 52, No 4 (2014) |
THE NEED AND POSSIBILITIES OF EARLY DIAGNOSIS OF ANKYLOSING SPONDYLITIS: COMMENTARIES ON THE PAPER «EARLY DIAGNOSIS OF ANKYLOSING SPONDYLITIS» (No. 4, 2013) AND DISCUSSION IN THE JOURNAL (No. 2, 2014) |
Abstract
PDF (Rus)
|
Sh. F. Erdes |
|
Vol 52, No 2 (2014) |
COMMENTS ON THE ARTICLE «EARLY DIAGNOSIS OF ANKYLOSING SPONDYLITIS» PUBLISHED IN No4, 2013 |
Abstract
PDF (Rus)
|
A. P. Rebrov, I. Z. Gaidukova |
|
1 - 20 of 20 Items |
|